CCM
RMD icon

Conway Capital Management’s ResMed RMD Stock Holding History

Conway Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,100
Closed -$240K – 43
2023
Q2 		$240K Sell
1,100
-550
-33% -$123K 0.17% 40
2023
Q1 		$361K Sell
1,650
-250
-13% -$54.2K 0.3% 32
2022
Q4 		$395K Hold
1,900
– – 0.4% 31
2022
Q3 		$415K Hold
1,900
– – 0.37% 32
2022
Q2 		$398K Buy
+1,900
New +$404K 0.36% 34

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Conway Capital Management's RMD Position: Q3 2023 in Review

Conway Capital Management sold out of ResMed (RMD) in Q3 2023, closing a stake of 1,100 shares — an estimated $240K sold.

Conway Capital Management first reported a position in RMD in Q2 2022 and held it in 5 quarters. The position peaked at $415K in Q3 2022. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Conway Capital Management reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Conway Capital Management sold 1,100 ResMed shares in Q3 2023, an estimated $240K.
  • Conway Capital Management first reported a position in ResMed in Q2 2022 and held it in 5 quarters.
  • Conway Capital Management's ResMed position peaked at $415K in Q3 2022.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Conway Capital Management's 13F filing for Q3 2023, filed 3 Dec 2024.